Ligand Pharma (LGND) Tops Q4 EPS by 1c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 313.52 +6.50 (2.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $307.02 | 52 Week High | $139.79 | |||
| Open | $309.99 | 52 Week Low | $82.07 | |||
| Day High | $317.76 | P/E | 729.12 | |||
| Day Low | $307.58 | EPS | $0.43 | |||
| Volume | 195,587 | |||||
